We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 48

Patent and Pharma Update - December 2015
  • Herbert Smith Freehills LLP
  • European Union, United Kingdom
  • December 29 2015

The Court of Appeal reversed the judge's finding that two of Leo Pharma's patents for a psoriasis ointment were invalid for obviousness. The key


The high court sets out a framework for dealing with enforcement of second medical use claims
  • Herbert Smith Freehills LLP
  • United Kingdom
  • September 17 2015

The long awaited decision on the merits in the well-publicised dispute between, inter alia, Generics (UK) Limited, Actavis Group and Warner-Lambert


Patent and pharma update June 2015
  • Herbert Smith Freehills LLP
  • European Union, United Kingdom
  • June 15 2015

The Court of Justice of the European Union has rejected Spain's second round of challenges to the Regulations establishing a unitary patent system via


Court of Appeal clarifies scope of Swiss form second medical use claims
  • Herbert Smith Freehills LLP
  • United Kingdom
  • June 1 2015

In an important judgment, the Court of Appeal has considered the interpretation of "Swiss form" second medical use claims i.e. claims directed to the


Patent and pharma update March 2015
  • Herbert Smith Freehills LLP
  • European Union, United Kingdom
  • March 27 2015

The ongoing dispute between Warner-Lambert and Actavis concerns developing law on how patents covering the second medical use of a


Patent and pharma update January 2015
  • Herbert Smith Freehills LLP
  • European Union, United Kingdom
  • January 22 2015

This second edition of our regular patent and pharma update provides a round-up of significant cases and developments from United Kingdom and


Patent and pharma update
  • Herbert Smith Freehills LLP
  • United Kingdom
  • November 11 2014

Welcome to our new bi-monthly patent and pharma update in which we aim to alert you to significant recent developments in patent law and practice


GSK v Comptroller - reference to the CJEU - can an adjuvant be the subject of an SPC?
  • Herbert Smith Freehills LLP
  • United Kingdom
  • March 26 2013

The Patents Court of England & Wales has requested that the CJEU clarifies the meaning of "product" in the SPC Regulation (Regulation 4692009). In


The CJEU opens the door for SPCs for new medical uses of known compounds
  • Herbert Smith Freehills LLP
  • United Kingdom
  • July 20 2012

Yesterday the CJEU handed down its decision in the eagerly awaited reference Neurim Pharmaceuticals v The Comptroller General of Patents concerning the possibility of obtaining an SPC based on a marketing authorisation ("MA"), where there has been an earlier MA for the same product but for a different use


The Supreme Court rules on the "industrial application" requirement to obtain a patent
  • Herbert Smith Freehills LLP
  • United Kingdom
  • November 4 2011

In Human Genome Sciences Inc v Eli Lilly & Co 2011 UKSC 51, the first patent decision since its formation in 2009, the UK Supreme Court has clarified the law on patentability and industrial application, in particular as its applies to the biotechnology sector